These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 27380317)

  • 61. Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')
    Findlay-Wilson S; Easterbrook L; Smith S; Pope N; Aldridge M; Humphries G; Schuhmann H; Ngabo D; Rayner E; Otter A; Coleman T; Hicks B; Halkerston R; Apostolakis K; Taylor S; Fotheringham S; Horton A; CanoCejas I; Wand M; Tree JA; Sutton M; Graham V; Hewson R; Dowall S
    Sci Rep; 2023 Aug; 13(1):13912. PubMed ID: 37626085
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases.
    Tharmalingam T; Han X; Wozniak A; Saward L
    Hum Vaccin Immunother; 2022 Apr; 18(2):1886560. PubMed ID: 34010089
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Zoonotic Influenza and Human Health-Part 2: Clinical Features, Diagnosis, Treatment, and Prevention Strategies.
    Mehta K; Goneau LW; Wong J; L'Huillier AG; Gubbay JB
    Curr Infect Dis Rep; 2018 Aug; 20(10):38. PubMed ID: 30069787
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.
    Lu J; Guo Z; Pan X; Wang G; Zhang D; Li Y; Tan B; Ouyang L; Yu X
    Respir Res; 2006 Mar; 7(1):43. PubMed ID: 16553963
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cross clade prophylactic and therapeutic efficacy of polyvalent equine immunoglobulin F(ab')2 against highly pathogenic avian influenza H5N1 in mice.
    Zhao Z; Yan F; Chen Z; Luo D; Duan Y; Yang P; Li Z; Peng D; Liu X; Wang X
    Int Immunopharmacol; 2011 Dec; 11(12):2000-6. PubMed ID: 21906698
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oseltamivir prophylactic regimens prevent H5N1 influenza morbidity and mortality in a ferret model.
    Boltz DA; Rehg JE; McClaren J; Webster RG; Govorkova EA
    J Infect Dis; 2008 May; 197(9):1315-23. PubMed ID: 18422444
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses.
    Paules CI; Lakdawala S; McAuliffe JM; Paskel M; Vogel L; Kallewaard NL; Zhu Q; Subbarao K
    J Infect Dis; 2017 Aug; 216(3):356-365. PubMed ID: 28633457
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment options for H5N1: lessons learned from the H1N1 pandemic.
    Reece PA
    Postgrad Med; 2010 Sep; 122(5):134-41. PubMed ID: 20861597
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy of a specific polyclonal equine F(ab')2 against avian influenza (H5N1) in ferrets: synergy with oseltamivir.
    Herbreteau CH; Denizot M; Lowther S; Riddell S; Frazer L; Haining J; Arkinstall R; Payne J; Harper J; Johnson D; Pasquier A; Middleton D; Saluzzo JF
    Immunotherapy; 2016 Sep; 8(9):1021-32. PubMed ID: 27380317
    [TBL] [Abstract][Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.